tiprankstipranks

Laurent Fischer Insider Profile

4 Followers
Laurent Fischer, CEO, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 7.69K shares in Adverum Biotechnologies (Ticker: ADVM). Most recently, Laurent Fischer ― shares of Tobira Therapeutics on ― for an estimated value of ―.
tipranks
Laurent Fischer

Laurent Fischer
Tobira Therapeutics (TBRA)
CEO, Director

Ranked #10,665 out of 78,624 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+70.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$259K
58.07%
41.93%
0.00%
A breakdown of Laurent Fischer's holdings

Insider Roles

Mirum Pharmaceuticals
(MIRM)
Director
Adverum Biotechnologies
(ADVM)
CEO and Director, Director
CTI BioPharma
(CTIC)
Director
Roles that Laurent Fischer holds in companies

Most Profitable Insider Trade

Stock:
Mirum Pharmaceuticals
(MIRM)
Rating:Informative Buy
Date:Sep 18, 2019 - Sep 18, 2020
Return:+112.00%
The most profitable trade made by Laurent Fischer

Laurent Fischer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TBRA
Tobira Therapeutics
$0.00
CTI BioPharma
Director
$0.00
Mirum Pharmaceuticals
Sep 18, 2019
Director
Informative Buy
19.71K
$150.19K
Adverum Biotechnologies
Aug 19, 2020
CEO and Director, Director
Informative Buy
100.00K
$108.46K
List of latest transactions for each holding click on a transaction to see Laurent Fischer's performance on stock

Laurent Fischer insider profile FAQ

What is the percentage of profitable transactions made by Laurent Fischer?
The percentage of profitable transactions made by Laurent Fischer is 100%.
    What is the average return per transaction made by Laurent Fischer?
    The average return per transaction made by Laurent Fischer is 70.70%.
      What stocks does Laurent Fischer hold?
      Laurent Fischer holds: TBRA, CTIC, MIRM, ADVM stocks.
        What was Laurent Fischer’s latest transaction?
        Laurent Fischer latest transaction was an Uninformative Buy of ―.
          What was Laurent Fischer's most profitable transaction?
          Laurent Fischer’s most profitable transaction was an Informative Buy of MIRM stock on September 18, 2019. The return on the trade was 112.00%.
            What is Laurent Fischer's role in Tobira Therapeutics?
            Laurent Fischer's role in Tobira Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.